Penumbra Inc.

PEN

Global healthcare company focused on innovative therapies for stroke and thromboembolism. Creator of the Jet 7 aspiration catheter system.

FDA ClearedCE Mark

$175.40

-0.8%

Market Data

Headquarters

Alameda, CA

CEO

Adam Elsesser

Founded

2004

Employees

4,500+

Sector

Neurovascular

Therapeutic Area

Neurology, Vascular

Stage

Public

Total Funding

Public (NYSE: PEN)

Regulatory Pipeline

Lightning Flash Thrombectomy

510(k) · Class II · Feb 2024

Cleared

Jet 7 MAX Reperfusion Catheter

510(k) · Class II · May 2023

Cleared

IPO

2015-09-17

$137M

NYSE

COMPLETE Stroke Registry

Active

Phase IV · US

No open positions listed.